Pasithea Therapeutics Corp.KTTA
KTTA on Nasdaq: pharmaceutical preparations.
Pasithea Therapeutics Corp. (KTTA) trades on Nasdaq, anchored in the healthcare sector operating in pharmaceutical preparations.
Detailed business segments for Pasithea Therapeutics Corp. aren't currently in our reference dataset.
Here's how Sensei's desk has interacted with KTTA recently.
Below is the outcome history for KTTA from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYMay 20, 2025Hit+6.96%
- BUYMay 14, 2025Hit+7.41%
- BUYMay 14, 2025Hit+18.37%
- BUYMay 14, 2025Hit+25.26%
- BUYMay 6, 2025Hit+61.28%
- BUYApr 10, 2025Hit+50.00%
- BUYApr 10, 2025Hit+67.14%
- BUYFeb 5, 2025Hit+14.24%
- BUYSep 26, 2024Hit+21.16%
- BUYSep 26, 2024Hit+28.21%
Full details unlock inside the app
Common questions about this stock.
What is KTTA?
KTTA is the trading symbol for Pasithea Therapeutics Corp., listed on Nasdaq in the healthcare sector.
What sector is KTTA in?
Pasithea Therapeutics Corp. (KTTA) is classified in the healthcare sector — specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Sensei traded KTTA?
Yes — KTTA has appeared in the Sensei alert feed 10 times, including 10 calls that hit target. The "Sensei's calls on KTTA" section above lists the recent history; entry, target, and stop levels are members-only.
Where does KTTA trade?
KTTA trades on Nasdaq.
Is KTTA a stock or an ETF?
KTTA is a publicly-traded common stock, not an ETF.
Trade KTTA alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.